| Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project KR Carson, AM Evens, EA Richey, TM Habermann, D Focosi, JF Seymour, ... Blood, The Journal of the American Society of Hematology 113 (20), 4834-4840, 2009 | 1073 | 2009 |
| Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse … KR Carson, D Focosi, EO Major, M Petrini, EA Richey, DP West, ... The lancet oncology 10 (8), 816-824, 2009 | 526 | 2009 |
| CD57+ T lymphocytes and functional immune deficiency D Focosi, M Bestagno, O Burrone, M Petrini Journal of leukocyte biology 87 (1), 107-116, 2010 | 312 | 2010 |
| Torquetenovirus: the human virome from bench to bedside D Focosi, G Antonelli, M Pistello, F Maggi Clinical Microbiology and Infection 22 (7), 589-593, 2016 | 248 | 2016 |
| Monoclonal antibody therapies against SARS-CoV-2 D Focosi, S McConnell, A Casadevall, E Cappello, G Valdiserra, ... The Lancet Infectious Diseases 22 (11), e311-e326, 2022 | 218 | 2022 |
| A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative … RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ... Oncotarget 4 (4), 502, 2013 | 207 | 2013 |
| Mucosal immune response in BNT162b2 COVID-19 vaccine recipients L Azzi, D Dalla Gasperina, G Veronesi, M Shallak, G Ietto, D Iovino, A Baj, ... EBioMedicine 75, 2022 | 194 | 2022 |
| Neutralising antibody escape of SARS‐CoV‐2 spike protein: risk assessment for antibody‐based Covid‐19 therapeutics and vaccines D Focosi, F Maggi Reviews in medical virology 31 (6), e2231, 2021 | 187 | 2021 |
| Are we overestimating the loss of beta cells in type 2 diabetes? L Marselli, M Suleiman, M Masini, D Campani, M Bugliani, F Syed, ... Diabetologia 57, 362-365, 2014 | 161 | 2014 |
| Convalescent plasma therapy for COVID-19: state of the art D Focosi, AO Anderson, JW Tang, M Tuccori Clinical microbiology reviews 33 (4), 10.1128/cmr. 00072-20, 2020 | 158 | 2020 |
| Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline M Tuccori, S Ferraro, I Convertino, E Cappello, G Valdiserra, C Blandizzi, ... MAbs 12 (1), 1854149, 2020 | 150 | 2020 |
| COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis JW Senefeld, M Franchini, C Mengoli, M Cruciani, M Zani, EK Gorman, ... JAMA Network Open 6 (1), e2250647-e2250647, 2023 | 142 | 2023 |
| Lithium and hematology: established and proposed uses D Focosi, A Azzara, RE Kast, G Carulli, M Petrini Journal of Leucocyte Biology 85 (1), 20-28, 2009 | 120 | 2009 |
| Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution D Focosi, F Maggi, M Albani, L Macera, V Ricci, S Gragnani, S Di Beo, ... Journal of Clinical Virology 47 (2), 189-192, 2010 | 116 | 2010 |
| Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells D Focosi, L Macera, U Boggi, LC Nelli, F Maggi Journal of general virology 96 (1), 115-117, 2015 | 109 | 2015 |
| Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge D Focosi, R Quiroga, S McConnell, MC Johnson, A Casadevall International journal of molecular sciences 24 (3), 2264, 2023 | 104 | 2023 |
| The impact of the COVID-19 “Infodemic” on drug-utilization behaviors: implications for pharmacovigilance M Tuccori, I Convertino, S Ferraro, E Cappello, G Valdiserra, D Focosi, ... Drug safety 43, 699-709, 2020 | 99 | 2020 |
| Progressive multifocal leukoencephalopathy and anti‐CD20 monoclonal antibodies: what do we know after 20 years of rituximab D Focosi, M Tuccori, F Maggi Reviews in medical virology 29 (6), e2077, 2019 | 99 | 2019 |
| Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence D Focosi, F Maggi, A Casadevall Viruses 14 (2), 187, 2022 | 96 | 2022 |
| Laparoscopic robot-assisted pancreas transplantation: first world experience U Boggi, S Signori, F Vistoli, S D'Imporzano, G Amorese, G Consani, ... Transplantation 93 (2), 201-206, 2012 | 94 | 2012 |
Fabrizio MaggiNational Institute for Infectious Diseases Lazzaro Spallanzani, RomeVerified email at inmi.it